UNSPSC 51351613: Mifepristone

This classification denotes an anti-progestin with the molecular formula C29H35NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 320T6RNW1F, chemically known as 17-beta-hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one but generally known as mifepristone, which bears US NIH Compound Identifier 55245. European Medicines Agency schedules Mifepristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08956MIG.

UNSPSC 51351613 Mifepristone is a Commodity code for the pharmaceutical product mifepristone, a medication used in medical abortion and certain gynecological procedures. State and local governments procure this drug through pharmacy benefit managers, state Medicaid programs, public health departments, and correctional health systems to support reproductive health services, emergency medical care, and inmate healthcare. The product is typically acquired as part of broader pharmaceutical procurement contracts rather than as a standalone line item, and sourcing is subject to state and federal regulatory constraints, including the Risk Evaluation and Mitigation Strategy (REMS) program and varying state legal restrictions on access and dispensing.

The source provided contains no recent state and local contract opportunities tagged to this code. Without active solicitation records, the geographic distribution of procurement activity and the specific mix of issuing bodies cannot be determined from available data.